These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 35662932)

  • 1. Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?
    Surma S; Sahebkar A; Urbański J; Penson PE; Banach M
    Front Nutr; 2022; 9():865497. PubMed ID: 35662932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Effects of Curcumin in Cardiovascular Diseases-Impact on Oxidative Stress and Mitochondria.
    Cox FF; Misiou A; Vierkant A; Ale-Agha N; Grandoch M; Haendeler J; Altschmied J
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?
    Vrablik M; Corsini A; Tůmová E
    Curr Atheroscler Rep; 2022 Mar; 24(3):161-169. PubMed ID: 35174437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.
    Kones R
    Vasc Health Risk Manag; 2013; 9():617-70. PubMed ID: 24174878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
    Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trigonelline and curcumin alone, but not in combination, counteract oxidative stress and inflammation and increase glycation product detoxification in the liver and kidney of mice with high-fat diet-induced obesity.
    Costa MC; Lima TFO; Arcaro CA; Inacio MD; Batista-Duharte A; Carlos IZ; Spolidorio LC; Assis RP; Brunetti IL; Baviera AM
    J Nutr Biochem; 2020 Feb; 76():108303. PubMed ID: 31812909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current pharmacotherapies for atherosclerotic cardiovascular diseases.
    Park JG; Oh GT
    Arch Pharm Res; 2019 Mar; 42(3):206-223. PubMed ID: 30725249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Most important advances in preventive cardiology during this past decade: Viewpoint from the American Society for Preventive Cardiology.
    Wong ND; Toth PP; Amsterdam EA;
    Trends Cardiovasc Med; 2021 Jan; 31(1):49-56. PubMed ID: 31882264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?
    Sahebkar A
    Biofactors; 2013; 39(2):197-208. PubMed ID: 23239418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin in age-related diseases.
    Tang C; Li L; Shi J; Wu D; Wang M; Wu Y; Yuan X
    Pharmazie; 2020 Nov; 75(11):534-539. PubMed ID: 33239125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of curcumin on retinal oxidative stress and inflammation in diabetes.
    Kowluru RA; Kanwar M
    Nutr Metab (Lond); 2007 Apr; 4():8. PubMed ID: 17437639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective.
    Kones R
    Drug Des Devel Ther; 2010 Dec; 4():383-413. PubMed ID: 21267417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of curcumin supplementation on markers of inflammation and oxidative stress among healthy overweight and obese girl adolescents: A randomized placebo-controlled clinical trial.
    Saraf-Bank S; Ahmadi A; Paknahad Z; Maracy M; Nourian M
    Phytother Res; 2019 Aug; 33(8):2015-2022. PubMed ID: 31206225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of turmeric (Curcuma longa) and its constituent (curcumin) on the metabolic syndrome: An updated review.
    Vafaeipour Z; Razavi BM; Hosseinzadeh H
    J Integr Med; 2022 May; 20(3):193-203. PubMed ID: 35292209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases.
    Shehzad A; Ha T; Subhan F; Lee YS
    Eur J Nutr; 2011 Apr; 50(3):151-61. PubMed ID: 21442412
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.